Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach.
Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach.
复制标题
DOI:
10.1371/journal.pone.0167760
复制
发表时间:
2016
期刊:
影响因子:
3.7
通讯作者:
Sarvazyan NA
中科院分区:
文献类型:
--
作者:
Muselimyan N;Swift LM;Asfour H;Chahbazian T;Mazhari R;Mercader MA;Sarvazyan NA
Currently, there are limited means for high-resolution monitoring of tissue injury during radiofrequency ablation procedures. To develop the next generation of visualization catheters that can reveal irreversible atrial muscle damage caused by ablation and identify viability gaps between the lesions. Radiofrequency lesions were placed on the endocardial surfaces of excised human and bovine atria and left ventricles of blood perfused rat hearts. Tissue was illuminated with 365nm light and a series of images were acquired from individual spectral bands within 420-720nm range. By extracting spectral profiles of individual pixels and spectral unmixing, the relative contribution of ablated and unablated spectra to each pixel was then displayed. Results of spectral unmixing were compared to lesion pathology. RF ablation caused significant changes in the tissue autofluorescence profile. The magnitude of these spectral changes in human left atrium was relatively small (< 10% of peak fluorescence value), yet highly significant. Spectral unmixing of hyperspectral datasets enabled high spatial resolution, in-situ delineation of radiofrequency lesion boundaries without the need for exogenous markers. Lesion dimensions derived from hyperspectral imaging approach strongly correlated with histological outcomes. Presence of blood within the myocardium decreased the amplitude of the autofluorescence spectra while having minimal effect on their overall shapes. As a result, the ability of hyperspectral imaging to delineate ablation lesions in vivo was not affected. Hyperspectral imaging greatly increases the contrast between ablated and unablated tissue enabling visualization of viability gaps at clinically relevant locations. Data supports the possibility for developing percutaneous hyperspectral catheters for high-resolution ablation guidance.
登录
查看更多内容
DOI:
10.1161/circep.114.001750
发表时间:
2014-10
期刊:
Circulation. Arrhythmia and electrophysiology
影响因子:
--
作者:
Swift L;Gil DA;Jaimes R 3rd;Kay M;Mercader M;Sarvazyan N
通讯作者:
Sarvazyan N
DOI:
10.1117/12.2043796
发表时间:
2014-03-21
期刊:
Proceedings of SPIE--the International Society for Optical Engineering
影响因子:
--
作者:
Lu G;Halig L;Wang D;Chen ZG;Fei B
通讯作者:
Fei B
DOI:
10.1111/j.1540-8167.2000.tb00068.x
发表时间:
2000-08-01
影响因子:
2.7
作者:
Saito, T;Waki, K;Becker, AE
通讯作者:
Becker, AE
影响因子:
1.9
作者:
PICKERING, JW;BOSMAN, S;VANGEMERT, MJC
通讯作者:
VANGEMERT, MJC
影响因子:
3.4
作者:
Baxter, WT;Mironov, SF;Pertsov, AM
通讯作者:
Pertsov, AM